The present study utilized a cultured myocardial cell 
Introduction
Recent studies have suggested that alterations in sarcolemmal membrane structure and function are causally related to the development of irreversible injury during myocardial ischemia. In intact ischemic heart models, previous studies have demonstrated the presence of sarcolemmal membrane defects by electron microscopy, which correlated with the time course of the onset of irreversible injury and the accumulation of tissue calcium (1, 2) . Previous studies in a perfused rabbit septal model related the decreases in myocardial contractile performance during ischemia with the development of increased sarcolemmal membrane cation permeability (3) . Acute myoAddress reprint requests to Dr. Chien. Received for publication 8 May 1984 and in revised form 11 January 1985. cardial infarction in man is characterized by leakage of cytosolic enzymes across the sarcolemmal membrane into the vascular space (4) . In addition, the accumulation of 99mtechnetium pyrophosphate, a probe for sarcolemmal membrane calcium permeability defects (5, 6) , has been demonstrated to be a sensitive marker of myocardial cell injury in clinical and animal studies.
Although it is becoming increasingly clear that alterations in sarcolemmal membrane structure and function may be involved in the development of irreversible cell injury (7), the biochemical basis responsible for these membrane changes is unknown. However, recent studies in an ischemic liver model suggested that the degradation of membrane phospholipids may be causally related to the loss of cell viability during ischemia (7, 8) . In this model, the degradation of membrane phospholipid was related temporally to the development of a membrane calcium permeability defect, a severalfold increase in tissue calcium content, and the development of irreversible damage in ischemically injured cells (8) . Pharmacologic inhibition of the phospholipid degradation by pretreatment with chlorpromazine resulted in protection against the alterations in calcium homeostasis and the development of irreversible cell injury (9) .
Recently, there have been several reports that arachidonic acid, a fatty acid normally present entirely in membrane phospholipid, accumulates in nonphospholipid species during myocardial ischemia (10) (11) (12) (13) (14) . In the present study, we utilized a cultured myocardial cell model to examine the relationship between phospholipid degradation and the progression of cell injury associated with a reduction in tissue high-energy phosphate concentrations produced by different metabolic inhibitors (deoxyglucose, oligomycin, cyanide, and iodoacetate). Phospholipid degradation was assessed by the release of radiolabeled arachidonate from membrane phospholipids. The hypotheses tested in these experiments were that the accumulation of free arachidonate is (a) an early indicator of membrane phospholipid degradation and (b) indicative of the development of severe, and possibly, irreversible cellular injury.
Methods
Materials. 1-['4C~palmitic acid (56 mCi/mmol) and (5, 6, 8, 9, 11, 12, modification of the method of Harary and Farley (15) . Whole hearts were isolated from 2-3-d-old rats and minced in a balanced salt solution containing Mg S04 7H20 (0.2 g/liter), NaCi (6.8 g/liter), KCI (0.4 g/liter), NaH2PO4H20 (1.5 g/liter), glucose (1 g/liter), and Hepes (4.76 g/liter) at pH 7.5. The myocardial cells were dispersed by the addition of a balanced salt solution containing pancreatin (Gibco Laboratories, Lawrence, MA) and 0.03% collagenase type II (Worthington Biochemical Corp., Freehold, NJ) and stirred at 370C. The supernatant was removed and discarded. The cells were incubated with fresh pancreatin-collagenase for 20 min at 370C. The supernatant was removed and centrifuged in a table-top centrifuge for 4 min at 1,400 rpm. The cells were resuspended in 2 ml of newborn calf serum (Gibco Laboratories) and kept at 370C. These steps were repeated a total of four times. The cell suspensions from each digestion were combined and centrifuged at 2,100 rpm for 6 min. The cells were resuspended in minimal essential medium (1.8 mM Ca"+) supplemented with 10% horse serum, 5% fetal calf serum, and 1% antibiotics (penicillin 10,000 U/ml, streptomycin 10,000 ug/ml). The cell suspensions were plated for 3 h and the unattached cells were removed and replated on either 35- Lipid analyses. Aliquots of the medium and cells were extracted for lipid analysis by the method of Bligh and Dyer (17) . To separate the neutral lipid and free fatty acids, aliquots of the lipid extracts were spotted on silica gel G thin-layer chromatography plates and developed with a solvent system of hexane/diethyl ether/acetic acid (80:20:1.2). The various phospholipid species were separated by thin-layer chromatography utilizing a solvent system of chloroform/methanol/acetic acid/water (75:45:10:6). The lipid spots were visualized under ultraviolet light by spraying with 0.02% dichlorofluoroscein, scraped directly into scintillation vials, or subsequently eluted for further lipid analyses.
The identity of the radiolabel after incorporation into myocardial lipids was obtained by high-pressure liquid chromatography of the bromophenacyl derivatives (13, 18) . The total myocardial cell lipid extract was concentrated under nitrogen, and saponified in 2 ml of 10% methanolic KOH and 0.5 ml of water. After incubation at 85°C for 1 h, 4 ml of water were added. The fatty acids were obtained by three successive acidified ether extractions. The ether extracts were concentrated under N2 and resuspended in 2 ml of acetonitrile, 20 resuspended in 500 Ml of acetonitrile, and injected directly into a Waters high-pressure liquid chromatograph. To achieve optimal separation of the fatty acyl species, an isocratic solvent of methanol/water/ acetonitrile (82:9:9) and a Supelco 5-,l Lichrosorb C-18 reverse phase column (Supelco Inc., Bellefonte, PA) and a flow rate of 1.5 ml/min were utilized (19) . Detection occurred at 254 nm and quantitation was performed by peak integration and comparison to a C-1 7 internal standard added to each sample. In some experiments, the eluate was collected for scintillation counting. In using these techniques, the recovery of exogenous arachidonate exceeded 90%.
Metabolite assays. ATP levels were measured by high-pressure liquid chromatography of the 6% perchloric acid extracts of the cultured cells. The medium was removed from the dishes and the myocardial cells were rinsed two times with sterile saline. The cells were scraped directly into I ml of ice-cold 6% perchloric acid, and the extracts were obtained by centrifugation. The time required to terminate each sample was <25 s. The extract was neutralized with SN KOH, filtered with a Waters SepPak, and injected directly into a Waters high-pressure liquid chromatograph. Quantitation and separation of the adenine nucleotides were accomplished with a Waters 10' Bondapak C-18 reverse-phase column, as described previously (20) . Creatine kinase in the medium was measured by spectrophotometric analysis (21) . Because creatine kinase activity is unstable in dilute medium (21) , these analyses were performed immediately after each experimental time point. Protein concentration was determined by the method of Lowry et al. (22) . Data were normalized to the milligrams of protein content within each dish before the addition of metabolic inhibitors, as assessed by measurements performed on a matched set of control cell dishes.
Morphology. During these experiments, the myocardial cell cultures were observed for beating activity and shape changes using a Nikoninverted microscope (Nikon, Inc., Garden City, NY) with phasecontrast optics. For (23) . Thin sections were cut on a Dupont-Sorvall MT 2 ultramicrotome (DuPont Instruments, Sorvall Biomedical Div., Newtown, CT) using a diamond knife. The sections were mounted on copper grids, and the preparations were stained with saturated alcoholic (20%) uranyl acetate and Reynolds' lead citrate (2.6%) (23) . The preparations were examined and photographed with a JEOL 100S transmission electron microscope (JEOL USA, Peabody, MA).
Statistical methods. Statistical analyses were performed by the two-tailed Student t test. Results were considered significant when P < 0.05.
Results
Morphology. Control cultures contained many aggregates of myocytes, which were observed to be beating regularly before fixation (Fig. I A) . After treatment of the myocardial cells with the combined inhibitors, deoxyglucose (DOG)' and oli-1. Abbreviations used in this paper: CK, creatine kinase; CN, cyanide; DOG, deoxyglucose; OLIGO, oligomycin.
Release ofArachidonate and Myocardial Cell Viability (Fig. I B) . By 8 h, many myocytes became markedly contracted, and some cells also showed focal vacuole formation (Fig. 1 C) . Contraction of the myocytes was accompanied by the formation of multiple sarcolemmal blebs, which protruded from the surfaces of the cells. Alternatively, some myocytes developed a single, large, raised, subsurface area (large bleb) along one side of the cell membrane. At this stage, the nuclei were shrunken, had condensed chromatin, and were surrounded by perinuclear halos. From 8 to 12 h, more contracted cells with blebs and nuclear changes were observed. Also, many cells exhibited an additional phase of contraction which was associated with rupture of the blebs. In preparations exposed to DOG, CN, or OLIGO alone, changes were limited to reduction in beating activity. Features of severe cell injury were not observed.
In preparations exposed to iodoacetate (0.3 X lo-4 M), a relatively rapid time course of cell injury occurred. By 1-2 h, beating activity ceased and many myocytes developed granular cytoplasm. By 2-4 h, severe cell injury became widespread, and the damaged myocytes showed features similar to those described for the DOG and OLIGO experiments.
Ultrastructural features of cell injury were generally similar with the different metabolic inhibitors. Control myocytes exhibited well-preserved organelles arranged in patterns typical of neonatal myocytes in culture (Fig. 2) . At an early stage of injury, myocytes exhibited disruption of the normal arrangement of myofibrils and formation of a disorganized mass of myofilaments (contraction bands) (Figs. 3 and 4). Nuclei exhibited variable degrees of swelling and generally contained small to medium-sized amorphous matrix (flocculent) densities (Fig. 5 A) . lodoacetate-treated cells exhibited particularly severe distortion of mitochondrial ultrastructure. No annular-granular densities indicative of early mitochondrial calcification were observed; however, the method of fixation used did not favor preservation of early calcific deposits (24) . The subsarcolemmal blebs were filled with finely granular cytoplasm. The blebs also contained a few mitochondria, but organelles were generally sparse in the blebs (Fig. 5 B) . Preparations at advanced stages of injury also contained variable numbers of completely disrupted and ruptured cells. The mitochondria in these cell fragments typically contained large amorphous matrix densities. High-energy phosphate levels. The treatment of cultured myocardial cells with either glycolytic (16) or respiratory inhibitors (16) resulted in significant decreases in cellular ATP content versus control ( Table I ). As shown in Tables I and II , treatment with iodoacetate resulted in a time dependent decrease in ATP content of the cultured myocardial cells. After 4 h of treatment, there was over a 70% decrease in ATP content vs. control. If the metabolic inhibitor was removed after 1 h of treatment and replaced with fresh medium, the cells were able to regenerate a normal ATP level. However, after 2-4 h of exposure to iodoacetate, the myocardial cells were unable to regenerate a normal ATP content. Thus, the myocardial cells appeared to be reversibly injured after 1 h of treatment and irreversibly injured after 4 h. Treatment with the combined metabolic inhibitors, DOG-OG or DOG-CN, also resulted in a time-dependent decrease in ATP content of Creatine kinase release. The time course of the release of creatine kinase (CK) into the extracellular medium correlated with the previously described time course of ATP depletion and defective ATP resynthesis (Fig. 7) . After 12 h. At that time, the myocardial cell lipids were extracted and subsequently derivatized with a bromophenacyl group, as described previously (17) . The derivatized fatty acids were separated subsequently by high-pressure liquid chromatography. Nonradioactive fatty acids were detected by ultraviolet absorption at 254 nm, whereas the origin of the radiolabel was identified by collecting fractions of the column eluate for 14C-or 3H-activity. As shown in Fig. 9 To further examine the relationship between the degradation of phospholipids and the development of membrane defects, cultured neonatal myocardial cells were exposed to various concentrations of iodoacetate. As shown in Fig. 10 , increasing concentrations of iodoacetate resulted in a corresponding increase in the release of arachidonate into the extracellular medium. (Fig. 10) .
Discussion
Although previous studies have demonstrated that phospholipid degradation is causally related to the loss of cell viability in ischemic liver (7-9), there have been several problems with directly extrapolating from the data found in ischemic liver to ischemic heart. First, after 1 h of fixed left anterior descending coronary artery occlusion in an open-chest, anesthetized canine model, there was unequivocal evidence of irreversible myocardial injury that was not accompanied by significant decreases in total phospholipid content (6) . In these studies, we found that the myocardial cell has a much slower rate and lower ties (X 20,000). (B) The sarcolemmal lining of a surface bleb exhibits focal discontinuities (X 45,000). extent of phospholipid depletion during ischemia compared to the ischemically injured liver cell (6, 8) . Second, Steenburgen and Jennings have found that the accumulation of lysophosphatides, phospholipid degradation products, does not correlate with the development of sarcolemmal defects in canine heart slices during conditions of autolysis (25) . Third, although some studies have demonstrated that pretreatment with chlorpromazine, a putative phospholipase inhibitor, protects ischemic myocardium (26) (27) (28) in others, chlorpromazine has failed to be similarly protective (29) .
To clarify the role of phospholipid degradation in the development of membrane defects and irreversible myocardial cell injury, it appeared that at least three factors would need to be considered. These factors are (a) the use of a myocardial model that contained a maximal number of myocytes compared to interstitial cells and where the structure and function of the myocardial cells could be examined over extended periods of time, (b) the utilization of a sensitive measure of phospholipid degradation, and (c) the evaluation of a uniform stimulus for ATP depletion. For these reasons, the current study utilized cultured neonatal rat heart cells to explore the relationship between membrane phospholipid degradation and the progression of cell injury during ATP depletion. The cultured myocardial cell model offers several important advantages for our studies. First, it employs myocardial cells that beat synchronously in culture where cell injury can be monitored for phospholipid perturbation than measurements of total phospholipid content. Third, cultured cells have a higher myocardial cell content than intact heart. Previous studies demonstrated that >70% of the cells in the intact heart are nonmyocardial cells (31) . To measure the contribution of nonmyocardial cells to arachidonate release, cultures containing different ratios of myocardial and nonmyocardial cells can be obtained. Fourth, the isolated myocardial cells may be exposed to constant concentrations of exogenous catecholamines and other hormones. Studies in several animal models have demonstrated redistribution and release of catecholamines during myocardial ischemia (32) , which could have independent effects on myocardial cell lipid metabolism distinct from the effects of highenergy phosphate depletion.
In that previous studies have demonstrated that that occur during myocardial ischemia. Thus, it should be expected that neonatal myocytes are more resistant than adult myocytes to oxygen deprivation. To obviate this difficulty, the present study utilized inhibitors of glycolysis and mitochondrial respiration to deplete high-energy phosphate levels. By using a variety of inhibitors, this model offered the opportunity to examine the effects of ATP depletion on the deacylation of arachidonate and the loss of cell viability when either glycolysis or fatty acid oxidation were impaired. Previous studies have demonstrated that neonatal myocytes react similarly to the adult heart when both glycolysis and fatty acid oxidation are inhibited (34, 35) . However, it should be noted that the direct relevance of this cultured cell model to in vivo ischemia remains to be determined. ATP depletion is only one of many biochemical alterations that occur during in vivo ischemia. Furthermore, each of these metabolic inhibitors may have additional effects on myocardial cells beyond simply the induction of ATP depletion. lodoacetate acts by inhibiting glyceraldehyde-3-phosphate dehydrogenase, but it may also inactivate many thiol containing enzymes. Oligomycin B may be a potent inhibitor of oxidative phosphorylation blocking mitochondrial ATP formation, but it may also create hydrophilic channels across membranes which may influence transmembrane potential and salt balance. Deoxyglucose may inhibit glycoprotein formation by substitution for mannose resulting in the formation of dolichol monophosphate deoxyglucose.
Previous studies in a perfused rabbit septal model have suggested that membrane dysfunction can occur within seconds of the induction of hypoxia (36) . In this model, a large leak of potassium occurs immediately after the removal of oxygen (36) . However, membrane alterations occurring early in the course of cell injury appear to involve dysfunction of specific membrane ion pumps and channels, rather than a more generalized and nonspecific increase in membrane permeability, which occurs in later stages of cell injury (3). By using this cultured myocardial cell model, the current study demonstrated a relationship between the release of radiolabeled arachidonate from membrane phospholipids, the development of sarcolemmal blebs, and the loss of cell viability. The loss of cell viability was manifest by (a) the release of creatine kinase into the extracellular medium, (b) the development of light and electron microscopic evidence of irreversible cell injury, and (c) the inability of the myocardial cells to regenerate ATP levels to control values on removal of the metabolic inhibitors. The relationships were evidenced during treatment with either glycolytic or respiratory inhibitors, and thus were not dependent on the inhibition of fatty acid oxidation. Those metabolic inhibitors that were unable to decrease ATP content below 40% of control were unable to The relationship between accumulation of radiolabeled arachidonate in the extracellular medium and the development of sarcolemmal defects suggested the possibility of a direct correlation between these two events during ATP depletion in cultured myocardial cells. There are at least two potential mechanisms by which the release of arachidonate from membrane phospholipids could be causally related to the development of sarcolemmal membrane injury during ATP depletion. First, the release of arachidonate may simply be a marker of the degradation and depletion of membrane phospholipids from the sarcolemmal membrane. It has previously been demonstrated that treatment of sarcolemmal membranes with exogenous phospholipases can result in a marked increase in their calcium permeability properties (6, 37) . However, it should be noted that the present study does not define the intracellular membrane from which the arachidonate is released. Therefore, it is still not clear how much of the arachidonate released into the extracellular medium during ATP depletion is derived from sarcolemmal membrane phospholipids vs. phospholipids of other organellar membranes. Alternatively, the transient accumulation of arachidonate and other unesterified fatty acids in the myocardial membrane may be directly affecting myocardial membrane structure and function. Because the radiolabeled arachidonate appeared in the extracellular medium, it is clear that the arachidonate must have diffused across the sarcolemmal membrane into the extracellular space. Katz and Messineo (38) (39) .
In summary, the present study has demonstrated the utility of a cultured myocardial cell model in evaluating the correlation between the release of arachidonate from membrane phospholipids and the progression of cell injury and loss of cell viability during ATP depletion. In this model, the current study demonstrates that (a) cultured myocardial cells display a timedependent progression of cell injury during ATP depletion; (b) the morphologic pattern of sarcolemmal membrane and irreversible cell injury in the cultured cells was similar to that found in intact ischemic canine myocardial models; (c) cultured myocardial cells release arachidonate from membrane phospholipids during ATP depletion; (c) in using two separate combinations of metabolic inhibitors, there was a close temporal and dose-response relationship between the release of arachidonate, the development of electron microscopic evidence of sarcolemmal defects, the release of creatine kinase into the extracellular medium, and the loss of the ability of the myocardial cells to regenerate ATP. Therefore, it is concluded that the release of arachidonate from myocardial membrane phospholipids is closely linked to the development of membrane defects and associated loss of cell viability in cultured myocardial cells during ATP depletion. If the release of arachidonate from membrane phospholipids is directly contributing to the development of irreversible myocardial cell injury, then the development and application of specific phospholipase inhibitors may be of value in protecting against these membrane alterations during cellular injury associated with marked ATP depletion. Further work will be required to define which myocardial phospholipases are releasing the arachidonic acid. In addition, this cultured cell model may prove useful in studying the biochemical link between ATP depletion and the accumulation of arachidonic acid.
